{
    "Trade/Device Name(s)": [
        "VITROS Immunodiagnostic Products AFP Reagent Pack",
        "VITROS\u00ae Immunodiagnostic Products AFP Reagent Pack"
    ],
    "Submitter Information": "Ortho-Clinical Diagnostics, Inc.",
    "510(k) Number": "K213626",
    "Predicate Device Reference 510(k) Number(s)": [
        "K983031"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LOJ"
    ],
    "Summary Letter Date": "June 15, 2022",
    "Summary Letter Received Date": "November 17, 2021",
    "Submission Date": "April 29, 2022",
    "Regulation Number(s)": [
        "21 CFR 866.6010"
    ],
    "Regulation Name(s)": [
        "Tumor-Associated Antigen Immunological Test System"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Alpha-fetoprotein (AFP)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITROS 5600 Integrated System"
    ],
    "Method(s)/Technology(ies)": [
        "Immunometric immunoassay",
        "Sandwich immunoassay",
        "Luminescence detection"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Calibrator",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for VITROS Immunodiagnostic Products AFP Reagent Pack for quantitative measurement of alpha-fetoprotein using immunometric assay on VITROS 5600 system.",
    "Indications for Use Summary": "For quantitative measurement of alpha-fetoprotein (AFP) concentrations in human serum using the VITROS 5600 Integrated system to aid in management of patients with non-seminomatous testicular cancer.",
    "fda_folder": "Immunology"
}